Hudson Bay Capital Management
HOOK

Hudson Bay Capital Management’s HOOKIPA Pharma HOOK Stock Holding History

Hudson Bay Capital Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-52,267
Closed -$460K – 856
2023
Q2 		$460K Buy
+52,267
New +$580K ﹤0.01% 631

Other funds holding HOOK

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hudson Bay Capital Management's HOOK Position: Q3 2023 in Review

Hudson Bay Capital Management sold out of HOOKIPA Pharma (HOOK) in Q3 2023, closing a stake of 52,267 shares — an estimated $460K sold.

Hudson Bay Capital Management first reported a position in HOOK in Q2 2023 and held it in 1 quarter. The position peaked at $460K in Q2 2023. 44 funds tracked by Wall St. Rank hold HOOK as of Q3 2023.

  • Hudson Bay Capital Management reported no remaining HOOKIPA Pharma position as of Q3 2023 after selling out during the quarter.
  • Hudson Bay Capital Management sold 52,267 HOOKIPA Pharma shares in Q3 2023, an estimated $460K.
  • Hudson Bay Capital Management first reported a position in HOOKIPA Pharma in Q2 2023 and held it in 1 quarter.
  • Hudson Bay Capital Management's HOOKIPA Pharma position peaked at $460K in Q2 2023.
  • 44 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2023.

Based on Hudson Bay Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.